Authors: SCHIFF E CIANCIARA J KOWDLEY K NORKRANS G PERRILLO R TONG M CROWTHER L WAKEFORD J WOESSNER M STEVENSON C BROWN N

Citation: E. Schiff et al., DURABILITY OF HBEAG SEROCONVERSION AFTER LAMIVUDINE MONOTHERAPY IN CONTROLLED PHASE-II AND PHASE-III TRIALS, Hepatology, 28(4), 1998, pp. 1-1

Authors: WAKEFORD J

Citation: J. Wakeford, CLINICAL-PHARMACOLOGY, VERSION-1.0, American journal of health-system pharmacy, 52(5), 1995, pp. 572-573